Serotonin Reuptake Inhibitors for the Treatment of Coexisting Depression and Psychosis in Dementia of the Alzheimer Type

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
William J BurkeSteven P Wengel

Abstract

Four patients, ages 75 to 92 years, with a dementia of the Alzheimer type, presented with accompanying depression and psychosis. In these patients, treatment with a selective serotonin reuptake inhibitor resulted in a dramatic clearing of not only the depressive symptoms but the psychosis as well. Treatment was well tolerated in all cases.

Citations

Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·D P Devanand, S R Levy
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·P N TariotI R Katz
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·D J Knesper
Jul 27, 2000·Journal of Geriatric Psychiatry and Neurology·F H RamadanA G Bassanelli
Jan 10, 2003·The Cochrane Database of Systematic Reviews·Jatinder BainsTom Dening
Sep 1, 2018·The Cochrane Database of Systematic Reviews·Robert DudasTom Dening
Mar 29, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·George T Grossberg, Abhilash K Desai
Jan 10, 2006·Arquivos de neuro-psiquiatria·Eliasz EngelhardtUNKNOWN Departamento de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia
Jul 12, 2002·International Journal of Geriatric Psychiatry·Krista L LanctôtClaudio A Naranjo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

BMJ : British Medical Journal
John R Geddes, Andrea Cipriani
© 2022 Meta ULC. All rights reserved